Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
C75
Cat. No.:
OB0225LY-0031
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
C75 is a specific fatty acid synthase inhibitor that inhibits tumor cell growth by interfering with lipid metabolic pathways.
Synonym:
C-75; 218137-86-1; 4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid; 4-Methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid
CAS No.:
218137-86-1
Compound CID:
4248455
Formula:
C14H22O4
Formula Weight:
254.32
Specification
Relative Density:
1.08 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
C75 is primarily used in obesity and metabolism-related cancer research.
Library Information
Targets:
Fatty acid synthase
Receptors:
Fatty acid synthase
Pathways:
Metabolism
Plate Number:
AOCL-1
Plate Location:
d3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
75.6 mg/mL; 297.3 mM
